These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preventing occupational exposure to hazardous drugs in the workplace. Ober S; Craven G J Infus Nurs; 2008; 31(1):18-9. PubMed ID: 18202554 [No Abstract] [Full Text] [Related]
3. [Guidelines for handling of therapeutic agents in the hospital and other health facilities]. Sykepleien; 1977 Oct; 64(16):918-20. PubMed ID: 244016 [No Abstract] [Full Text] [Related]
4. Cytotoxic drug handlers--monitoring in the occupational health setting. DesRoches P AAOHN J; 2003 Mar; 51(3):106-8. PubMed ID: 12670096 [TBL] [Abstract][Full Text] [Related]
5. [Employers poorly oriented to chemical substances?]. Bakke KA J Sykepleien; 1991 Sep; 79(15):12. PubMed ID: 1799544 [No Abstract] [Full Text] [Related]
6. Pregnancy and work-related health risks. Williams N Practitioner; 1995 Apr; 239(1549):238-40, 242-3. PubMed ID: 7596973 [No Abstract] [Full Text] [Related]
7. Are you protecting yourself from hazardous drugs? Eisenberg S ONS Connect; 2009 Jul; 24(7):20. PubMed ID: 19645163 [No Abstract] [Full Text] [Related]
8. [Chemical resistance of latex gloves]. Sartorelli P; Montomoli L Med Lav; 2008; 99(2):96-101. PubMed ID: 18510271 [TBL] [Abstract][Full Text] [Related]
9. [How does the information on drugs function in Norway. Question to the physicians]. Lunde PK Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2103-4. PubMed ID: 5479229 [No Abstract] [Full Text] [Related]
10. Hazardous drugs. Black LA; Presson AC Occup Med; 1997; 12(4):669-85. PubMed ID: 9353816 [TBL] [Abstract][Full Text] [Related]
11. [Reporting of drug-induced complications]. Naess K Tidsskr Nor Laegeforen; 1965 Sep; 85(18):1413-5. PubMed ID: 5882532 [No Abstract] [Full Text] [Related]
12. A survey of the status of hazardous drug awareness and control in a sample Massachusetts nursing population. Fuller TP; Bain EI; Sperrazza K J Occup Environ Hyg; 2007 Nov; 4(11):D113-9. PubMed ID: 17763072 [No Abstract] [Full Text] [Related]
13. [Adverse effects and the press]. Noess K Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2557. PubMed ID: 1412271 [No Abstract] [Full Text] [Related]
15. [Adverse effects as sensations]. Haess K Tidsskr Nor Laegeforen; 1991 May; 111(14):1763-4. PubMed ID: 2063391 [No Abstract] [Full Text] [Related]
16. [Status of side effects. 3. Intensified registration of adverse effects. What should be reported?]. Myhr K; Lunde PK Tidsskr Nor Laegeforen; 1989 Nov; 109(31):3226-8. PubMed ID: 2595689 [No Abstract] [Full Text] [Related]
17. [The work of the Adverse Effects Committee]. Borchgrevink CF Tidsskr Nor Laegeforen; 1987 Mar; 107(9):871-3. PubMed ID: 3590130 [No Abstract] [Full Text] [Related]
18. [Status of side effects. 1. Background and current status]. Lunde PK; Myhr K Tidsskr Nor Laegeforen; 1989 Nov; 109(31):3223-4. PubMed ID: 2595688 [No Abstract] [Full Text] [Related]